Sector revisions DexCom, Inc.

Stocks

Market Closed - Nasdaq Other stock markets 16:00:00 2026-06-18 EDT			5-day change	1st Jan Change
72.47 ^USD	+1.74%		-3.85%	+9.19%

06-16	AI Can Play 'Significant' Role in Tech for Managing Diabetes, Says David Roman	MT
06-15	Piper Sandler Adjusts Price Target on DexCom to $88 From $75, Maintains Overweight Rating	MT

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	1y. EPS revision	1y. Revenue rev.	Nbr of analysts
DEXCOM, INC.			24
ABBOTT LABORATORIES			24
MEDTRONIC PLC			26
HOYA CORPORATION			15
CENCORA, INC.			12
BECTON, DICKINSON AND COMPANY			13
MEDLINE INC.	-	-	27
WEST PHARMACEUTICAL SERVICES, INC.			14
TERUMO CORPORATION			13
STERIS PLC			7
SARTORIUS STEDIM BIOTECH			14
ZIMMER BIOMET HOLDINGS, INC.			20
FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED			12
SOLVENTUM CORPORATION			13
ALIGN TECHNOLOGY, INC.			14
GLOBUS MEDICAL, INC.			11
BAXTER INTERNATIONAL INC.			12
INSULET CORPORATION			23
DEMANT A/S			19
BIO-RAD LABORATORIES, INC.			5
Average			16
Weighted average by Cap.			19